Sex-Selection Abortion Kills Entire U.S. Female Population

Opinion   |   Rebecca Taylor   |   Dec 28, 2011   |   6:41PM   |   Washington, DC

In a recent conversation, my sister-in-law commented on how many girls we have in our growing family. I have three girls, my brother has three girls and my husband’s brother has three girls.

I responded by saying that while boys are great too, it is a good thing that we are having so many girls. With 163 million “missing” girls in Asia, which is the equivalent to the entire female population of the United States, someone needs to be having girls. Lots and lots of girls.

Which is why I support the Prenatal Non-Discrimination Act or PRENDA for short. It would make aborting a girl just because she is a girl illegal in the United States. You would think that making it illegal to abort a girl just because she is a girl would be a feminist’s dream. The feminists must be rallying in support of such legislation, right? They are not. They say that sex selection in the United States is non-existent. They call sex selective abortion a “trumped up bill for a trumped up problem.”

That seems like the only play in the pro-abortion play book. Just pretend. First, pretend a fetus is not a living human organism. Now, pretend that sex selection does not happen in America. Except there is evidence that Asians are practicing sex-selective abortions here in the United States. A study done with data from the 2000 U.S. Census shows a clear son preference in Chinese, Koreans, and Asian Indians. The normal male to female ratio is 1.05 to 1. Researchers found that for third children where the older siblings were girls the ratio of boys to girls in these populations was an grossly unnatural 1.5 to 1. The researchers concluded that sex selection is occurring and it is likely in the prenatal stage.

Richard Miniter wrote in Forbes that a study in the San Francisco Bay Area, two clinics that service a high Asian population reported that 89% of women carrying girls aborted. Miniter also reported coercion:

And, too often, it wasn’t their choice. South-Asian women, pregnant with daughters, reported incredible pressure by in-laws and husbands to produce sons and not daughters. Husbands threatened divorce or abandonment, others struck, choked or kicked their wives in the abdomen in the hopes of preventing a daughter. One woman said that her Indian mother-in-law threatened to take poison if she could not produce a son.

So feminists opposed to PRENDA are not only opposed to protecting girls in the womb from discrimination but are also opposed to giving women legal protection against pressure from their husbands and in-laws to abort their girls.

See feminists that oppose PRENDA really do not want to protect women. They want to protect ideas instead. Ms. Magazine called PRENDA “an affront our rights to privacy, to bodily autonomy, and to mobilize in concert to create change and solidarity in our communities—based on our priorities and experiences, our visions for the future and our agency.” Some feminists would rather protect the elusive and vague ideas of “experiences,” “visions” and “agency” than protect actual girls from being exterminated just because they don’t have a Y chromosome.

Do I think PRENDA will solve all of the sex selection abortions in America? No. Only getting rid of legalized abortion all together will do that. But it is important that the United States has laws on the books that state we will not stand for aborting girls just because they are girls. In the meantime, I, along with true feminists that support PRENDA, will continue to celebrate the birth of girls everywhere knowing they are desperately needed in today’s world. Note: Rebecca Taylor is a clinical laboratory specialist in molecular biology, and a practicing pro-life Catholic who writes at the bioethics blog Mary Meets Dolly. She has been writing and speaking about Catholicism and biotechnology for five years and has been interviewed on EWTN radio on topics from stem cell research and cloning to voting pro-life. Taylor has a B.S. in Biochemistry from University of San Francisco with a national certification in clinical Molecular Biology MB (ASCP).